Vireo Growth's August 13, 2026 filing shows that control-like operating responsibility and legal asset ownership changed at different times. Vireo had managed 17 PharmaCann Colorado dispensaries since March under a Management Services Agreement; on August 7 the acquisition closed, that agreement ended, and the assets became fully integrated into Vireo's Colorado platform. A separate secured revolving credit facility also closed that day.
The question this map answers is: how do the management phase, asset closing, consideration, and new financing relate without being mistaken for one transaction? The answer is a two-lane map. One lane follows the dispensaries from seller assets to managed operations to acquired assets. The other follows a new Bank of Montreal facility to its borrowers, collateral, and permitted uses.
Source scope and observation window
MyMap observed Vireo's Form 8-K, filed August 13 under SEC accession 0001104659-26-095427, at 4:25 AM Pacific Time that day. The filing's earliest reported event is August 7, the closing date for both the credit agreement and the asset acquisition. The filing incorporates earlier acquisition documents and attaches the current credit agreement and second amendment to the asset purchase agreement.
The controlling source is Vireo's filing and its SEC-hosted exhibits. The map does not use the company's press-release adjectives to establish integration success, credit availability, or future growth.
Lane one: management preceded ownership
Vireo agreed to acquire the Colorado retail assets in December 2025. The filing says a Management Services Agreement became effective in March 2026, allowing Vireo to manage the acquired assets, integrate operations, and implement its operating platform before closing.
On August 7, the PharmaCann transaction closed. The Management Services Agreement concluded, and the operations became fully integrated into Vireo's existing Colorado platform. The filing identifies 17 retail dispensary locations and says Vireo's operational Colorado footprint expanded to 56 locations.
These states need precise definitions:
| Relationship | Meaning in this map | What it does not prove |
|---|---|---|
| managed | Vireo operated the assets under the disclosed services agreement | ownership, title, or unrestricted control |
| acquired | the asset purchase closed and disclosed assets moved under the transaction | ownership of every PharmaCann business or entity |
| integrated | Vireo describes the acquired operations as integrated into its Colorado platform | quantified synergies or identical legal ownership of every location |
| footprint | operational dispensary count stated by Vireo | a license-by-license regulatory inventory |
The useful visual insight is the state transition: seller assets → managed before closing → acquired at closing. A flat announcement that Vireo “added 17 stores” erases the months when operations and ownership were intentionally out of sync.
Consideration was shares plus assumed liabilities
The filing puts total consideration at approximately $48.7 million. It consisted of 3,004,751 Vireo subordinate voting shares and the assumption of certain liabilities tied to the acquired assets and business.
Not all shares moved immediately. Vireo says 2,943,023 consideration shares were released from escrow and distributed to the collateral agent at closing. Another 61,728 shares were held back and are scheduled for automatic release nine months after closing, subject to the asset purchase agreement.
That creates three different capital edges:
- Vireo issued consideration shares for the acquired assets;
- most shares moved from escrow to the seller-side collateral agent at closing;
- a smaller holdback remains time-bound rather than immediately released.
The map labels the future release as contractual, not completed. It does not calculate the future market value of the shares or infer which ultimate stakeholders receive them.
Lane two: the revolver is connected, but separate
On August 7, Prolific Supply LLC, an indirect Vireo subsidiary, other domestic subsidiaries, and BWAB Canada ULC entered a senior secured asset-based revolving credit agreement with the participating lenders and Bank of Montreal as administrative agent, letter-of-credit issuer, and swing-line lender. BMO Capital Markets is named as arranger and bookrunner.
The facility provides commitments up to $85 million, with a possible $20 million increase to $105 million if the agreement's conditions are satisfied. It matures August 7, 2031. The obligations are secured by first-priority interests, subject to permitted liens, in substantially all assets of the borrowers and other loan parties; subsidiary guarantees and a parent equity pledge add further support.
The filing permits proceeds to be used for several jobs: refinancing specified existing debt, paying facility fees and expenses, funding working capital and capital expenditure, supporting general corporate purposes, and financing permitted acquisitions.
This is where the two lanes touch. “Permitted acquisitions” makes the facility relevant to Vireo's acquisition capacity. But the filing does not say the revolver funded the $48.7 million PharmaCann consideration. The consideration is described separately as shares plus assumed liabilities. The map therefore uses a dotted “may fund permitted acquisitions” edge, not a solid “funded this acquisition” arrow.
What the controlling source confirms
The filing confirms the August 7 closing date; the 17 acquired dispensaries; the increase to 56 operational Colorado locations; the approximate consideration and its components; the released and held-back share counts; the conclusion of the Management Services Agreement; and the facility's parties, commitment range, maturity, collateral structure, and permitted uses.
It also confirms that Vireo CEO John Mazarakis is a partner of Chicago Atlantic Group, an affiliate of the prior lender whose debt may be refinanced with facility proceeds. That is a disclosed relationship. The map does not infer misconduct, preferential terms, or a causal reason for the refinancing.
What MyMap derives
MyMap derives the two-lane structure, the “operations before ownership” state sequence, and the distinction between a financing capacity edge and a transaction-funding edge. The source supplies the events and relationships; MyMap chooses the graph that prevents them from collapsing together.
The visual also groups the borrowers and guarantors into a “Vireo loan parties” trust zone. This is a readability device, not a claim that every Vireo entity is a borrower or guarantor.
What remains unknown
The filing does not show how much of the revolver was drawn at observation time, the final borrowing base, whether the $20 million increase will occur, the amount of each assumed liability, the allocation of value among the 17 dispensaries, or the ultimate economic recipients of the consideration shares.
It also does not provide a license-by-license Colorado ownership chart or independently verify operational integration. Pro forma financial information is not in this filing; Item 9.01 says it will be filed by amendment as soon as practicable and no later than the stated regulatory deadline.
A shared closing date is not proof that one transaction funded the other. Relationship maps must preserve the difference between “same day,” “permitted use,” and “documented flow of funds.”
Reproducible mapping method
To reproduce the map, start from the 8-K index and extract each agreement, party, dated state, asset set, consideration component, and expressly permitted use. Give every edge a verb from the source: manages, acquires, issues, releases, holds back, lends, guarantees, secures, or may fund.
Then apply three tests:
- Clock test: keep agreement, management, closing, and future-release dates separate.
- Entity test: distinguish Vireo Growth, its subsidiaries, PharmaCann parties, the collateral agent, lenders, and Bank of Montreal's named roles.
- Flow test: use a solid arrow only for a disclosed transfer or obligation; use a dotted edge for a permission or possible future use.
Readers building a similar closing dossier can adapt this structure in a MyMap flowchart, keeping legal state changes on one lane and capital relationships on another. The owned tool is a drafting handoff, not corroboration.
Practical next step and update trigger
The next primary-source checkpoint is Vireo's promised Form 8-K amendment with pro forma financial information. At that point, append the new financial view without rewriting the August 7 control and ownership sequence.
Update this dossier sooner if Vireo discloses a facility draw, a changed share holdback, a regulatory change affecting the acquired locations, or a correction to the store count. Cite the 8-K for transaction facts and MyMap for the two-lane analysis; do not reuse the dotted financing edge as proof of a cash flow the source never states.